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Abstract
Background
The timing of the biannual WHO influenza vaccine composition selection and production
cycle has been historically directed to the influenza seasonality patterns in the temperate
regions of the northern and southern hemispheres. Influenza activity, however, is poorly
understood in the tropics with multiple peaks and identifiable year-round activity. The evi-
dence-base needed to take informed decisions on vaccination timing and vaccine formula-
tion is often lacking for the tropics and subtropics. This paper aims to assess influenza
seasonality in the tropics and subtropics. It explores geographical grouping of countries into
vaccination zones based on optimal timing of influenza vaccination.
Methods
Influenza seasonality was assessed by different analytic approaches (weekly proportion of
positive cases, time series analysis, etc.) using FluNet and national surveillance data. In
case of discordance in the seasonality assessment, consensus was built through discus-
sions with in-country experts. Countries with similar onset periods of their primary influenza
season were grouped into geographical zones.
Results
The number and period of peak activity was ascertained for 70 of the 138 countries in the
tropics and subtropics. Thirty-seven countries had one and seventeen countries had two
distinct peaks. Countries near the equator had secondary peaks or even identifiable year-
round activity. The main influenza season in most of South America and Asia started
between April and June. The start of the main season varied widely in Africa (October and
December in northern Africa, April and June in Southern Africa and a mixed pattern in tropi-
cal Africa). Eight “influenza vaccination zones” (two each in America and Asia, and four in
Africa and Middle East) were defined with recommendations for vaccination timing and vac-
cine formulation. The main limitation of our study is that FluNet and national surveillance
data may lack the granularity to detect sub-national variability in seasonality patterns.
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Conclusion
Distinct influenza seasonality patterns, though complex, could be ascertained for most
countries in the tropics and subtropics using national surveillance data. It may be possible
to group countries into zones based on similar recommendations for vaccine timing and
formulation.
Introduction
Influenza disease affects up to 10% of the world’s population every year [1]. The World Health
Assembly resolved in 2003 to increase the use of seasonal influenza vaccines to protect individ-
uals at high risk for influenza and related complications [2]. The World Health Organization
(WHO) Global Action Plan for Influenza Vaccines, launched in 2006, aims to promote
demand and use of seasonal influenza vaccine as a strategy towards pandemic preparedness
[3]. Seasonal influenza activity peaks coincide with the colder months (November–February
and May–October) in the temperate regions of the northern and southern hemisphere respec-
tively [4]. The WHO Global Influenza Surveillance and Response System reviews bi-annually
the antigenic characteristics of influenza viruses circulating globally during the year to predict
which variants are likely to predominate in the following influenza season. It then recommends
the vaccine composition for the following influenza season in the Northern and Southern
hemisphere, in February and September, respectively [5]. Vaccine production takes about 6–7
months. The Northern hemisphere formulation is available by October whereas the Southern
hemisphere formulation is available by April of the following year [6].
The last decade has seen an increasing number of low and middle income countries in the
tropics and subtropics introducing seasonal influenza vaccination in their immunization pro-
grams or expanding to include maternal influenza immunization, especially in the Latin Amer-
ica region [7–10]. The biannual vaccine composition–production cycle is timed suitably for the
temperate regions with distinct influenza seasonality patterns. Seasonal influenza activity is less
well defined and poorly understood in the tropics and subtropics with multiple peaks and iden-
tifiable year-round activity that frequently coincides with the rainy season [11,12]. Influenza
surveillance and pandemic preparedness has improved in many countries in the tropics and
subtropics in recent years and now provides the opportunity to ascertain seasonality in coun-
tries with less distinct patterns [13]. This paper reports on a collaborative effort to assess influ-
enza seasonality in the tropics and subtropics using four different approaches. It further
defines geographical grouping of countries into vaccination zones with the aim to propose sim-
plified operational guidance to countries on when to vaccinate and which formulation to use.
Methods
We brought together four major global analysis efforts conducted in 2014 that assessed global
influenza seasonality by the Centers for Disease Control and Prevention (CDC), Netherlands
Institute for Health Services Research (NIVEL), Program for Appropriate Technology
(PATH), and the WHO. From these analyses, data were sought from 138 countries and territo-
ries (except Australia) situated wholly or partly between the 38th lateral north and south that
typically have a tropical and subtropical climate ecosystem. The groups used different statistical
approaches to analyse laboratory confirmed influenza activity from the FluNet reporting sys-
tem and / or national surveillance data (Table 1). FluNet was the largest global database for
influenza virological surveillance maintained by the WHO Global Influenza Surveillance and
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Table 1. Data source, definitions and analytic approach to assess influenza seasonality.
PATH NIVEL CDC WHO
Data source 1) FluNet 1) FluNet, 2) National
surveillance data
1) FluNet, 2) PAHO, 3)
National surveillance data
1) FluNet
Seasons analysed 2010–2015, 131 countries FluNet: 2010–2014, 131
countries. National surveillance
data: 2000–2014, 18 countries
2002–2014, 16 countries of
Central and South America
2010–2014, 131 countries
Inclusion Laboratory conﬁrmed data Laboratory conﬁrmed data Laboratory conﬁrmed data.
Countries with more than 3
years of monthly seasonal
data
Laboratory conﬁrmed data
Exclusion 1) 2009–2010, 2)
Countries that reported
less than 50 inﬂuenza
cases in a year were
excluded for that year
1) 2009 (2009–2010 for NH),
2) Season with less than 10
specimens per week (FluNet),
3) Season with less than 50
inﬂuenza cases or less than 20
consecutive weeks of reported
data (National surveillance
data)
1) 2009–2010, 2) Monthly
data from countries that
reported less than 12
months of continuous data
3) Less than 10 samples
tested each month
1) 2009–2010, 2) Year with
less than 100 inﬂuenza
positive cases
Approach used Weekly case proportion i.e.
weekly proportion of
positive cases over all
positive cases for inﬂuenza
within that year. Then
converted to monthly case
proportion.
FluNet: Months with high, low
and no inﬂuenza activity were
identiﬁed by eyeballing each
year in the FluNet database.
This assessment was made by
two persons working
independently. The annual
assessments were then
summarised by taking the
average level of inﬂuenza
activity per month (no, low or
high). National surveillance
data: Data were pooled on a
monthly basis and a case
proportion (i.e. a monthly
proportion of samples testing
positive for inﬂuenza) was
calculated [16].
Weekly case proportion i.e.
weekly proportion of
samples testing positive for
inﬂuenza. Then converted to
monthly case proportion
[17]. Binomial model to
predict the monthly inﬂuenza
activity as a factor of
historical monthly and yearly
activity–log(p/(1-p)) = year
+ month p = prop. of monthly
inﬂuenza positives / total no.
of monthly sample for
testing. Also analysed
whether peak inﬂuenza
percentage positivity
occurred during similar
months each year.
Time Series analysis. Missing
values in time series replaced
with either 0 or moving
average (imputation). Time
series plot (observed and
imputed) to check if imputation
makes sense. Autocorrelation
function plot to display
dependency between time
points.
Criteria to deﬁne peak
/ period of increased
inﬂuenza activity
Month with 10% or more of
total yearly cases of
inﬂuenza for two or more
years between 2010 and
2015. Second set of
increased inﬂuenza activity
separated by 2 or more
months of non-peak
activity.
1) FluNet: Eye-balling by two
persons independently. The
periods of increase inﬂuenza
activity were deﬁned as
months with high levels of
activity. 2) National
surveillance data: Peak
deﬁned as week with highest
no. of cases. If highest no.
reported in two or more weeks,
peak deﬁned as the central
week of the 3-wk or 5-wk
period with the highest no. of
reported cases. Then counted
the no. of times the peak
occurred in each month of the
year. The monthly proportion of
samples testing positive for
inﬂuenza was used to identify
months which had high levels
of inﬂuenza activity.
Predicted inﬂuenza activity
exceeded the annual
median proportion of positive
cases for at least 2
consecutive months. Start of
epidemic deﬁned as the ﬁrst
month when activity
exceeded and remained
above annual median
proportion. End of epidemic
deﬁned as the month when
activity remained below the
annual median proportion for
at least one month.
Time -series analysis to deﬁne
peak. Decomposition plot to
decompose time series into
seasonal, trend and residual
components.
Criteria to deﬁne year-
round activity
Eight or more months of
increased ﬂu activity, or 3
or more peaks of inﬂuenza
activity each separated by
at least 2 months
Inﬂuenza was on average
identiﬁed each month of the
year
Inﬂuenza was on average
identiﬁed each month of the
year
doi:10.1371/journal.pone.0153003.t001
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Response System since 1995 [14]. The FluNet database provided virological and epidemiologi-
cal information on clinical specimens routinely collected from patients consulting at sentinel
hospitals and clinics and tested for influenza virus by the National Influenza Centres in a coun-
try. The FluNet database was contributed by 143 National Influenza Centres in 113 countries
and accessed at http://www.who.int/influenza/gisrs_laboratory/flunet/en/. FluNet database for
the seasons 2010 to 2015 was included for analysis. Many countries also conducted sentinel
surveillance for influenza-like illness and severe acute respiratory illness with or without labo-
ratory confirmation for influenza infection. National surveillance data for the seasons 2002 to
2014 was included for analysis wherever available. The influenza pandemic year 2009–2010
was excluded as the influenza activity in this period was not seasonal by definition. The criteria
for including data varied across sites and ranged from at least 50 to 100 reported influenza
cases and / or at least 20 consecutive weeks of reported data in a year. The WHO researchers
used time series analysis using the R statistical package, decomposed into seasonal, trend and
residual components for years with more than 100 influenza cases to define peak activity. Sig-
nificant levels in the autocorrelation function were regarded as signs of seasonality. The other
groups estimated the monthly proportions of positive cases amongst all positives or amongst
all tested within the year as a proxy for influenza activity. The PATH researchers determined a
monthly proportion of positive influenza cases out of all positive cases within a given year and
considered a month to have increased influenza activity if the monthly proportion was 10%
for two or more years between 2010–2014. The CDC researchers further used a binomial
model factored on month and year of activity to predict the monthly influenza activity i.e.
ði:e:; log Proportion of all samples testing positive for influenza
1 Proportion of all samples testing positive for influenza
 
¼ year þmonthÞ
CDC also quantiﬁed the weighted average proportion of samples testing positive for inﬂu-
enza as a sensitivity analysis [15]. Two months or more of consecutive inﬂuenza activity above
the annual median was considered epidemic. Criteria for deﬁning a peak, number of peaks or
thresholds for increased inﬂuenza activity differed (Table 1).
As a first step, a common database was agreed upon to define the number of peaks and the
start and end month of the primary and secondary peak for each country. Influenza seasonality
(number of peaks, identifiable year-round activity and period of increased influenza activity)
was assessed by four different analytic approaches for each country and compared with season-
ality reported in published literature. We assessed each country to decide if any of the methods
resulted in a date range that was an outlier from the other methods. Discordance in the assess-
ment of the number of peaks or where the start of the season differed by more than one month
using the different analytic approaches, was resolved through discussions amongst the
researchers and in-country experts by combining both the raw output of our individual meth-
ods and our knowledge of the strength of the data to determine outliers. The number of peaks
and period of increased influenza activity assessed by each method and the consensus pattern
for each country is given in S1 Table. Countries were further categorized as those with one or
two distinct peaks with and without identifiable year-round influenza activity.
In the next step, countries with onset period of their primary influenza activity in the same
calendar quarter were grouped into geographically contiguous zones that would indicate simi-
lar guidelines for vaccination timing. A country with inadequate data was presumed to have
similar seasonality pattern as its neighbour for whom information was available, and grouped
in the same zone as the neighbour. In the context where a country with no data adjoined neigh-
bours that belonged to different zones, the country was grouped with the neighbour that shared
the same latitude [12,17,18].
Influenza Seasonality in the Tropics
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Results
Of the 138 countries and territories in the tropics and subtropics, 73 had functional national
influenza surveillance systems that reported to the Global Influenza Surveillance and Response
System between 2002 and 2015. Influenza seasonality was assessed in 70 countries and territories
representing about 73% of the world’s population. Seasonality could not be ascertained in 22 of
the 48 countries in Africa due to inadequate data. The seasonality patterns assessed by the four
different analytic approaches were discordant for 29 countries (21%), mostly in Africa (58%).
Most countries in Central and South America showed a single distinct peak except Belize,
Colombia, Costa Rica, Ecuador, and Paraguay which showed two distinct peaks (Fig 1). Saha-
ran Africa and countries in the Middle East showed a single distinct peak (exception–Jordan
and Qatar which had two distinct peaks). Two distinct peaks were seen in Mali, Burkina Faso,
Ethiopia, Mali, Rwanda. Furthermore, identifiable year-round activity was seen in countries sit-
uated nearer the equator (Côte d’Ivoire, Ghana, Togo, Nigeria, Cameroon, Kenya, Uganda,
United Republic of Tanzania and Madagascar). Most countries in South and south-east Asia
(Bangladesh, Cambodia, Lao People’s Democratic Republic, Myanmar, Nepal and Philippines)
showed a single distinct peak (exception–Pakistan, India, Bhutan, Sri Lanka and Thailand
showed two distinct peaks). Countries situated near the equator (Indonesia, Malaysia, Singa-
pore and Viet Nam) showed identifiable year-round activity.
Fig 2 shows countries with primary or secondary periods of increased influenza activity in the
four quarters of the calendar year. The primary period of influenza activity in most countries in
Central and South America, South and Southeast Asia was from April to June. India showed an
additional secondary peak between October and December. Africa presented a complex picture
with increased activity from October to December in the northern region, from April to June in
the southern region and throughout the year in sub-Saharan Africa near the equator.
The start of the primary influenza season in most of tropical and subtropical America
(except Mexico and Guatemala) and Asia (except Pakistan, Sri Lanka and Indonesia) was
between April and June, similar to the seasonality pattern seen in the southern hemisphere
temperate regions. The main season started a little later, between July and September, in
Fig 1. Influenza seasonality patterns—number of peaks and identifiable year-round activity. The number in parenthesis in legend indicate number of
countries.
doi:10.1371/journal.pone.0153003.g001
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Fig 2. Primary and secondary influenza activity in the tropics and subtropics.
doi:10.1371/journal.pone.0153003.g002
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Honduras and Jamaica in the Americas, and Nepal, Bhutan, Lao People’s Democratic Republic
and Cambodia in Asia (Fig 3). The start of the main season varied in Africa. Most of Saharan
Africa, the Middle East extending eastwards as far as Pakistan showed a seasonality pattern
similar to the northern hemisphere temperate regions (start of the main influenza season
between October and December). The primary season started between January and March in
some countries of sub-Saharan Africa (Mali, Niger, Tunisia, Ethiopia, Rwanda, Malawi and
Madagascar). West Africa (stretching from Senegal to the Central African Republic) and South
Africa showed a seasonality pattern that was similar to that seen in the temperate regions of the
southern hemisphere. The start of the primary influenza season was not ascertainable for
Kenya and Malaysia (Table 2). Presuming that the southern and northern formulation become
available in April and October respectively, the latest vaccine formulation would be available
just prior to the onset of the primary influenza season for 45 out of 70 countries (47% of the
world’s population) situated in the tropics and subtropics. In 23 countries (many of them in
sub-Saharan Africa), there would be a 3 to 6 months lag between the onset of the primary influ-
enza season and the availability of the existing vaccine formulation or the availability of the
next updated vaccine formulation.
Countries with similar onset period of their main influenza season were grouped into eight
geographically defined ‘influenza vaccination zones’ (Fig 4). Two zones each were proposed for
America and Asia. A single zone was proposed for North Africa, the Middle East extending fur-
ther eastwards to Pakistan. Separate zones were proposed for Saharan, equatorial and southern
region of Africa. A southern hemisphere formulation is recommended for most of America
(except Guatemala, Jamaica and Mexico), sub-Saharan Africa (except DR Congo, Malawi,
Rwanda and United Republic of Tanzania), and tropical Asia (except Sri Lanka and Indonesia)
to be given in April (Table 3). A northern hemisphere formulation to be given in October is
appropriate for north Africa and the Middle East up to Pakistan.
Discussion
Laboratory confirmed influenza surveillance data were analysed for 70 countries representing
73% of the world population living in the tropics and subtropics to assess influenza seasonality.
Fig 3. Start of the primarymain influenza season. The number in parenthesis in legend indicate number of countries.
doi:10.1371/journal.pone.0153003.g003
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Despite differences in the surveillance methods, definition of thresholds, data sources, and sea-
sons analysed, the different statistical approaches were consistent in ascertaining the number
of peaks, and periods of increased influenza activity for majority (41 out of 70) of the countries
Table 2. Influenza seasonality assessment for Kenya, Malaysia.
No. of peaks Primary period of increased
inﬂuenza activity
Secondary period of increased
inﬂuenza activity
Seasons analysed Data source
Kenya Year-round Cannot be ascertained
CDC 2, year-round Jul-Nov Feb-Mar 2007–2013 ILI/SARI
surveillance
NIVEL 1–2, year-round Jan-Mar Jul-Nov 2007–2013 FluNet & Surv
data
PATH Year-round 2010–2014 FluNet
WHO Year-round 2010–2014 FluNet
Published
[19,20]
1, year-round 3,
year-round
Jul-Nov Mar-Apr & Oct-Nov Jul 2007–2013 ILI/SARI
surveillance
Malaysia Year-round Cannot be ascertained
CDC
NIVEL 1–2, year-round Varied 2007–2010 FluNet
PATH 2 Jan-Feb Apr-May 2010–2014 FluNet
WHO Year-round Inconclusive 2006–2008,
2010,2011,2014
FluNet
Published
[18,21–23]
Year-round May-Aug 2006–2011 ILI/SARI
(Note: Consensus ﬁnding in boldface)
doi:10.1371/journal.pone.0153003.t002
Fig 4. Seasonal influenza vaccination zones.
doi:10.1371/journal.pone.0153003.g004
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assessed. Though the timing of the peaks varied slightly from season to season and some coun-
tries had an atypical peak occasionally, distinct patterns of increased influenza activity could be
ascertained for most countries in the tropics and subtropics [24]. As seen in other studies,
countries situated near to the equator were likely to have multiple peaks with or without identi-
fiable year-round activity [18]. A distinct seasonality pattern could not be ascertained for two
out of the 70 countries assessed, viz. Kenya and Malaysia. Notwithstanding, evidence from
Kenya suggests that either formulation would be effective as each covered 50% the isolated
viruses in Kenya (unpublished work).
Though the timing of the biannual influenza vaccine selection–production cycle has worked
well for the temperate regions of the northern and southern hemispheres, its applicability to
the seasonality seen in the tropics and subtropics is thought to be uncertain [25,26]. Our find-
ings suggests that the optimal timing for the annual seasonal influenza vaccination campaign
based on the start of the main influenza activity period, could be identified for most countries
in the tropics and subtropics. Countries such as Brazil, China and India that have subnational
variability in their seasonality pattern and countries situated near the equator with significant
influenza activity throughout the year may need to consider alternate strategies based on their
local seasonality [27–30]. The past experience of Peru in managing two schedules of vaccine
procurement, deployment and withdrawal within the same year has been exceedingly challeng-
ing from a regulatory and logistics perspective (personal communication–PAHO). Instead,
countries should consider strategies to increase vaccination coverage using the most appropri-
ate formulation.
The FluNet data and the national surveillance data on which the analyses are based have
inherent limitations. Though the FluNet database is the largest and most widely used global
database for influenza strain information, its primary purpose is virological surveillance though
it may be used for assessing seasonality and disease burden [31]. These data may not always be
Table 3. Influenza vaccination zones.Countries with data extrapolated from neighbours are in italics.
Vaccination zone Countries from tropics and subtropics Vaccine
formulation
Vaccination
timing
North & Central America Guatemala, Jamaica, Mexico NH October
Central & South America
(except–Guatemala, Jamaica)
Anguilla, Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Bolivia
(Plurinational State of), Brazil, Cayman Islands, Chile, Colombia, Costa Rica,
Cuba, Dominica, Dominican Republic, Ecuador, El Salvador, French Guiana,
Grenada, Guyana, Haiti, Honduras, Montserrat, Netherland Antilles, Nicaragua,
Panama, Paraguay, Peru, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and
the Grenadines, Suriname, Trinidad and Tobago, Turks and Caicos Islands,
Uruguay, Venezuela (Bolivarian Republic of)
SH April
North Africa & Middle East Algeria, Burkina Faso, Chad, Djibouti, Egypt, Eritrea, Ethiopia, Libya, Mali,
Mauritania, Morocco, Niger, Somalia, Sudan, Tunisia, Afghanistan, Bahrain, Iran
(Islamic Republic of), Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Pakistan,
Qatar, Saudi Arabia, Syrian Arab Republic, United Arab Emirates, Yemen
NH October
West Africa Benin, Cameroon, Central African Republic, Côte d'Ivoire, Gambia, Ghana,
Guinea, Guinea-Bissau, Liberia, Nigeria, Senegal, Sierra Leone, Togo, Uganda
SH April
Equatorial Africa (except–Kenya,
Uganda)
Burundi, Congo (the), Democratic Republic of the Congo, Equatorial Guinea,
Gabon, Madagascar, Malawi, Rwanda, United Republic of Tanzania
NH October
Southern Africa Angola, Mozambique, Namibia, South Africa, Zambia, Zimbabwe SH April
Tropical Asia Bangladesh, Bhutan, Cambodia, India, Lao PDR, Myanmar, Nepal, Philippines,
Thailand, Viet Nam
SH April
Equatorial Asia (except—
Malaysia)
Brunei Darussalam, Indonesia, Singapore, Sri Lanka NH October
(Note: Kenya and Malaysia were not assigned to any vaccination zone; NH = Northern hemisphere; SH = Southern hemisphere)
doi:10.1371/journal.pone.0153003.t003
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nationally representative and may lack the granularity to detect sub-national variability in sea-
sonality patterns. Moreover, the data depend on reporting by the national influenza centres
and sometimes subject to under-reporting.
The influenza vaccination zone is similar in concept to the 18 influenza transmission zones
defined by the WHO since the 2009 pandemic, to monitor and report on the transmission
dynamics of influenza activity globally [32]. Unlike the influenza vaccination zone, the influ-
enza transmission zone does not take into consideration the vaccination perspective though
one would expect a large degree of concordance between the two. The identification of influ-
enza vaccination zones are an attempt to propose simplified operational guidance to countries
in the tropics and subtropics on when to vaccinate and which formulation to use.
The proposed influenza vaccination zones are subject to a few limitations. First, the zones
especially in Sub-Saharan Africa may be re-defined in alternate ways as more national surveil-
lance data to ascertain seasonality become available. Second, the assumptions and criteria for
grouping countries with inadequate data with their neighbours are also open to debate. Third,
this approach assumes that either the northern or southern hemisphere vaccine formulation is
the most appropriate in terms of antigenic match of the vaccine virus with circulating influenza
viruses in the tropics and subtropics. While this may not always be the case, current data sup-
port this assumption. Seasonal influenza viruses evolve antigenically onward to escape immune
pressure in the population [33]. Antigenic mapping of A/H3N2 influenza virus isolated in
Thailand between 2002 and 2006 showed no evidence that the antigenic evolution was any dif-
ferent from influenza viruses isolated elsewhere in the world. A similar analysis for A(H3N2),
B-Victoria and B-Yamagata for 17 other countries in the tropics and subtropics, also showed
no evidence for substantial differences from the global patterns of antigenic evolution [34].
Finally, lack of disaggregated sub-national data may mask local and regional variations in sea-
sonality patterns. It is possible that nationally aggregated data for a country with two single but
distinct peaks at the subnational level at different times of the year may lead to an incorrect
assessment of seasonality for that country. In such situations, countries need to assess seasonal-
ity at the subnational level for decisions on vaccination timing and formulation to use.
Thus once the time of vaccination is determined by local seasonality, from an antigenic evo-
lution perspective, the most recent WHO influenza virus vaccine recommendation should be
used, independent of the geographic location of the country. To this extent, this paper proposes
simplified operational guidance for influenza immunization to countries on when to vaccinate
and which formulation to use.
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S1 Table. Influenza seasonality in the tropics and subtropics. The consensus seasonality pat-
tern for each country is shown in the first row for each country.
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